Steve Fodor, chairman and CEO of Affymetrix, will receive the 2005 ABRF Award from the Association of Biomolecular Resource Facilities at the organization’s annual meeting in Savannah, Ga., in February 2005.
Zymomyx has named Peter Wagner as its new CEO. He has served as chief technology officer of Zyomyx since 1998 and is a founder of the firm. Wagner succeeds Robert Monaghan.
Gene Logic has elected J. Stark Thompson as non-executive chairman of the board. The election follows the creation of two new management positions and stems from Gene Logic’s decision to “separate the roles of chairman and CEO,” the company said. Thompson was formerly president and CEO of Life Technologies.
Andrew Carr, former president of discovery systems for GE Healthcare, is now functioning in an advisory role within the company. Carr was replaced by Joel McComb in August, who joined the company from a position as president and CEO of Innovadyne Technologies. McComb’s previous work experience included heading the primary care division of Beckman Coulter.